NK cell isolation from liver biopsies: Phenotypic and functional analysis of low cell numbers by flow cytometry

Frontiers in Immunology

Volumn 4, Issue MAR, 2013, Pages

  Li, Ning ^a,b   Yung, Gisella L Puga ^a   Pradier, Amandine ^a   Toso, Christian ^a   Giostra, Emiliano ^a   Morard, Isabelle ^a   Spahr, Laurent ^a   Seebach, Jörg D ^a  

^a University Hospital and Medical Faculty ^*  (Switzerland)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CD107a; Collagenase; Flow cytometry; Human NK cells; IFN ; Intrahepatic lymphocytes; Liver biopsy

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; CYTOKINE; DEOXYRIBONUCLEASE I; GAMMA INTERFERON; GELATINASE A; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

ADULT; ARTICLE; CELL FUNCTION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; DEGRANULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBIOLOGY; LIVER BIOPSY; LIVER CELL; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION;

EID: 84880838425     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00061     Document Type: Article

References (44)

1. Abuzakouk, M., Feighery, C., and O'Farrelly, C. (1996). Collagenase and Dispase enzymes disrupt lymphocyte surface molecules. J. Immunol. Methods 194, 211-216.
2. Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., et al. (2010). Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 138, 325-335. e321-e322.
3. Aktas, E., Kucuksezer, U. C., Bilgic, S., Erten, G., and Deniz, G. (2009). Relationship between CD107a expression and cytotoxic activity. Cell. Immunol. 254, 149-154.
4. Alter, G., Malenfant, J. M., and Altfeld, M. (2004). CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22.
5. Apolinario, A., Majano, P. L., Alvarez-Perez, E., Saez, A., Lozano, C., Vargas, J., et al. (2002). Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am. J. Gastroenterol. 97, 2861-2870.
6. Blom, K. G., Qazi, M. R., Matos, J. B., Nelson, B. D., Depierre, J. W., and Abedi-Valugerdi, M. (2009). Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained. Clin. Exp. Immunol. 155, 320-329.
7. Bonorino, P., Ramzan, M., Camous, X., Dufeu-Duchesne, T., Thelu, M. A., Sturm, N., et al. (2009). Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J. Hepatol. 51, 458-467.
8. Bravo, A. A., Sheth, S. G., and Chopra, S. (2001). Liver biopsy. N. Engl. J. Med. 344, 495-500.
9. Cholongitas, E., Senzolo, M., Standish, R., Marelli, L., Quaglia, A., Patch, D., et al. (2006). A systematic review of the quality of liver biopsy specimens. Am. J. Clin. Pathol. 125, 710-721.
10. Crispe, I. N. (2009). The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147-163.
11. Curry, M. P., Norris, S., Golden-Mason, L., Doherty, D. G., Deignan, T., Collins, C., et al. (2000). Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization. J. Immunol. Methods 242, 21-31.
12. Dessouki, O., Kamiya, Y., Nagahama, H., Tanaka, M., Suzu, S., Sasaki, Y., et al. (2010). Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment. Biochem. Biophys. Res. Commun. 393, 331-337.
13. Doherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E., et al. (1999). The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163, 2314-2321.
14. Doherty, D. G., and O'Farrelly, C. (2000). Innate and adaptive lymphoid cells in the human liver. Immunol. Rev. 174, 5-20.
15. Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., et al. (2007). Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204, 667-680.
16. Eisenhardt, M., Glassner, A., Kramer, B., Korner, C., Sibbing, B., Kokordelis, P., et al. (2012). The CXCR3(+)CD56bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis C. PLoS ONE 7:e38846. doi:10.1371/journal.pone.0038846
17. Flynn, L, Carton, J., Byrne, B., Kelehan, P., O'Herlihy, C., and O'Farrelly, C. (1999). Optimisation of a technique for isolating lymphocyte subsets from human endometrium. Immunol. Invest. 28, 235-246.
18. Gao, B., Jeong, W. I., and Tian, Z. (2008). Liver: an organ with predominant innate immunity. Hepatology 47, 729-736.
19. Hintermann, E., Bayer, M., Pfeilschifter, J. M., Luster, A. D., and Christen, U. (2010). CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation. J. Autoimmun. 35, 424-435.
20. Ishiyama, K., Ohdan, H., Ohira, M., Mitsuta, H., Arihiro, K., and Asahara, T. (2006). Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 43, 362-372.
21. Jinushi, M., Takehara, T., Tatsumi, T., Yamaguchi, S., Sakamori, R., Hiramatsu, N., et al. (2007). Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 120, 73-82.
22. Kawarabayashi, N., Seki, S., Hatsuse, K., Ohkawa, T., Koike, Y., Aihara, T., et al. (2000). Decrease of CD56(+) T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32, 962-969.
23. Kramer, B., Korner, C., Kebschull, M., Glassner, A., Eisenhardt, M., Nischalke, H. D., et al. (2012). NKp46 (High) expression defines a NK cell subset that is potentially involved in control of HCV replication and modulation of liver fibrosis. Hepatology 56, 1201-1213.
24. Krueger, P. D., Lassen, M. G., Qiao, H., and Hahn, Y. S. (2011). Regulation of NK cell repertoire and function in the liver. Crit. Rev. Immunol. 31, 43-52.
25. Lanier, L. L., Le, A. M., Civin, C. I., Loken, M. R., and Phillips, J. H. (1986). The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136, 4480-4486.
26. Lefkowitch, J. H. (2007). Liver biopsy assessment in chronic hepatitis. Arch. Med. Res. 38, 634-643.
27. Meier, U. C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., et al. (2005). Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J. Virol. 79, 12365-12374.
28. Mondelli, M. U., Varchetta, S., and Oliviero, B. (2010). Natural killer cells in viral hepatitis: facts and controversies. Eur. J. Clin. Invest. 40, 851-863.
29. Morsy, M. A., Norman, P. J., Mitry, R., Rela, M., Heaton, N. D., and Vaughan, R. W. (2005). Isolation, purification and flow cytometric analysis of human intrahepatic lymphocytes using an improved technique. Lab. Invest. 85, 285-296.
30. Mulder, W. M., Koenen, H., Van De Muysenberg, A. J., Bloemena, E., Wagstaff, J., and Scheper, R. J. (1994). Reduced expression of distinct T-cell CD molecules by collagenase/DNase treatment. Cancer Immunol. Immunother. 38, 253-258.
31. Nair, V., Fischer, S. E., and Adeyi, O. A. (2010). Non-viral-related pathologic findings in liver needle biopsy specimens from patients with chronic viral hepatitis. Am. J. Clin. Pathol. 133, 127-132.
32. Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T., and Spengler, U. (2006). Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55, 869-877.
33. Nattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H., Leifeld, L., et al. (2005). The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 166, 443-453.
34. Norris, S., Collins, C., Doherty, D. G., Smith, F., McEntee, G., Traynor, O., et al. (1998). Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 28, 84-90.
35. Pham, B. N., Mosnier, J. F., Walker, F., Njapoum, C., Bougy, F., Degott, C., et al. (1994). Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B. Clin. Exp. Immunol. 97, 403-410.
36. Shi, F. D., Ljunggren, H. G., La Cava, A., and Van Kaer, L. (2011). Organ-specific features of natural killer cells. Nat. Rev. Immunol. 11, 658-671.
37. Tajiri, K., Shimizu, Y., Tsuneyama, K., and Sugiyama, T. (2009). Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 21, 673-680.
38. Tian, Z., Chen, Y., and Gao, B. (2012). Natural killer cells in liver disease. Hepatology. doi:10.1002/hep.26115. [Epub ahead of print].
39. Tran, A, Yang, G., Doglio, A., Ticchioni, M., Laffont, C., Durant, J., et al. (1997). Phenotyping of intrahepatic and peripheral blood lymphocytes in patients with chronic hepatitis C. Dig. Dis. Sci. 42, 2495-2500.
40. Uhrberg, M. (2005). The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 19, 707-709.
41. Varchetta, S., Mele, D., Mantovani, S., Oliviero, B., Cremonesi, E., Ludovisi, S., et al. (2012). Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 56, 841-849.
42. Yamagiwa, S., Kamimura, H., and Ichida, T. (2009). Natural killer cell receptors and their ligands in liver diseases. Med. Mol. Morphol. 42, 1-8.
43. Yamagiwa, S., Matsuda, Y., Ichida, T., Honda, Y., Takamura, M., Sugahara, S., et al. (2008). Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells. Hepatol. Res. 38, 664-672.
44. Zhang, Z., Zhang, S., Zou, Z., Shi, J., Zhao, J., Fan, R., et al. (2011). Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 53, 73-85.